Literature DB >> 8071304

High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients.

R S Tanneau1, A Henry, F Rouhart, B Bourbigot, B Garo, Y Mocquard, J Y Goas.   

Abstract

BACKGROUND: Patients with self-induced water intoxication usually tolerate a large, rapid increase in plasma sodium without developing osmotically induced central pontine myelinolysis. However, we have previously reported a case of clinically suspected pontine myelinolysis in a patient with self-induced water intoxication. The purpose of our study was to investigate if a subgroup of these patients may also be vulnerable to neurologic complications of hyponatremia therapy.
METHOD: Over a 10-year period, we identified retrospectively 12 polydipsic patients having a total of 24 episodes of symptomatic hyponatremia with plasma sodium < or = 115 mmol/L. The mode of treatment, the kinetics of correction, and the neurologic outcome were recorded. The presence of alcoholism was noted.
RESULTS: Seven patients recovered uneventfully from 19 episodes of symptomatic hyponatremia. Five patients had delayed neurologic complications. Late therapy and/or respiratory arrest might have been associated with the complications for 2 patients. The other 3 patients experienced clinical features of central pontine myelinolysis leading to death in 1. Patients with neurologic complications had a higher maximal 24-hour increase in plasma sodium concentration (21.8 +/- 3.9 vs. 15.5 +/- 5.1 mmol/L, p < .02), and a higher incidence of both overcorrection to hypernatremia and chronic alcoholism, often associated with poor nutrition. All 5 patients became water intoxicated at home, and 2 patients with pontine dysfunction had subacute rather than acute hyponatremia.
CONCLUSION: A large rapid increase in plasma sodium may also be detrimental in patients with self-induced water intoxication when they are alcoholic, malnourished, and have nonacute hyponatremia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071304

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

Review 1.  Treatment of Severe Hyponatremia.

Authors:  Richard H Sterns
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-02       Impact factor: 8.237

2.  Clinical management of SIADH.

Authors:  Peter Gross
Journal:  Ther Adv Endocrinol Metab       Date:  2012-04       Impact factor: 3.565

3.  Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.

Authors:  Jason C George; Waleed Zafar; Ion Dan Bucaloiu; Alex R Chang
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-05       Impact factor: 8.237

4.  Predictors of outcome in hospitalized patients with severe hyponatremia.

Authors:  Chike M Nzerue; Henry Baffoe-Bonnie; Wei You; Babajide Falana; Shifan Dai
Journal:  J Natl Med Assoc       Date:  2003-05       Impact factor: 1.798

Review 5.  The Changing Role of Sodium Management in Cirrhosis.

Authors:  Blanca Lizaola; Alan Bonder; Elliot B Tapper; Angela Mendez-Bocanegra; Andres Cardenas
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

6.  Intracranial hypertension secondary to psychogenic polydipsia.

Authors:  Vanessa M Gleason; Niels D Martin
Journal:  J Emerg Trauma Shock       Date:  2012-04

7.  Treatment of severe symptomatic hyponatremia.

Authors:  Srijan Tandukar; Helbert Rondon-Berrios
Journal:  Physiol Rep       Date:  2019-11

8.  The Effect of the Dose of Isotonic Saline on the Correction of Serum Sodium in the Treatment of Hypovolemic Hyponatremia.

Authors:  Jorge Gabriel Ruiz-Sánchez; Diego Meneses; Cristina Álvarez-Escolá; Martin Cuesta; Alfonso Luis Calle-Pascual; Isabelle Runkle
Journal:  J Clin Med       Date:  2020-11-05       Impact factor: 4.241

9.  Persistent hiccups in cancer patient: a presentation of syndrome of inappropriate antidiuretic hormone induced hyponatremia.

Authors:  Alka Goyal; Syed Mehmood; Seema Mishra; Sushma Bhatnagar
Journal:  Indian J Palliat Care       Date:  2013-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.